![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, May 29, 2014 12:12:17 PM
The MMTC press release did not state that the joint effort with the university was a Phase 1 clinical trial. Here is the lead statement for the press release - Micro Imaging Technology Enters Phase 1 of Its Collaboration With Northern Michigan University.
Information regarding clinical trials testing as established by the Federal Drug Administration can be found at the following URL.
http://www.fda.gov/drugs/resourcesforyou/consumers/ucm143534.htm
The collaboration does not involve drug testing. Upon obtain staphylococcus identifiers, it is my understanding that the company will work with the AOAC Research Institute to validate the identification process.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM